Publications
This video focuses on the Maternal and Infant-Focused Neonatal Abstinence Syndrome (NAS) Investment Program’s interventions that have improved care and reduced hospital length of stay, NICU admissions, and need for pharmacologic treatment for opioid-exposed newborns and their mothers.
The Maternal and Infant-Focused Neonatal Abstinence Syndrome (NAS) Investment Program tested interventions to improve quality of care for opioid-exposed newborns and their mothers. This report evaluates the impact of both the NAS investment program and of specific interventions.
This legislatively-mandated report presents analyses and recommendations regarding the Commonwealth’s entry into the Nurse Licensure Compact (NLC), including an overview of nurse job vacancies in Massachusetts, whether entry into the NLC would increase the Commonwealth’s emergency and pandemic preparedness, and evaluation of other states’ entry into the NLC.
This impact brief focuses on successful quality improvement interventions from the Maternal and Infant-Focused Neonatal Abstinence Syndrome (NAS) Investment Program for families impacted by opioid use disorder, including increasing non-pharmacologic interventions, optimizing pharmacologic treatment and hospital utilization, and improving access to wraparound treatments.
This impact brief includes an overview of the Targeted Cost Challenge Investments program including program awardees, implemented care models, and the impacts of these initiatives.
This legislatively-mandated report analyzes the impact of COVID-19 on the health care delivery system in Massachusetts, including short-term and long-term implications.
The Office of Patient Protection (OPP), operated by the HPC, is responsible for regulating and administering certain health care consumer protections for the Commonwealth. OPP is a resource for individuals who want to become more informed and empowered health care consumers. This annual report provides a comprehensive overview of the activities of the Office in the year 2019.